Bimetallic Nanoparticle Composition for Stable Antimicrobial Potency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antimicrobial and anticancer agents, such as silver nanoparticles and chemotherapeutic drugs, face challenges with stability, consistency, and efficacy against drug-resistant infections and cancers, necessitating improved cytotoxic compositions.
Innovation Solution
A nanoparticle composition combining metals like silver, gold, platinum, and surfactants with antibiotics and drugs, such as tetracycline and doxorubicin, to enhance stability and efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver nanoparticles are used as antimicrobial agents, then broad-spectrum antibiotic activity is achieved, but stability in air and control of size and shape in aqueous environment deteriorate
Solution Approach 1:
The patent combines silver nanoparticles with gold nanoparticles to form bimetallic composite particles. This composite structure leverages the antimicrobial properties of silver while gold provides enhanced stability and catalytic activity, resolving the contradiction between antimicrobial effectiveness and compositional stability.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the nanoparticle system by controlling the size ratio, shape, and surface composition of the bimetallic particles. By optimizing these parameters, the patent achieves both stable colloidal suspension in aqueous environments and effective antimicrobial activity.
2Reliability
If concentrated silver nanoparticle solutions are used to achieve effectiveness, then antimicrobial potency is improved, but toxicity and handling difficulty worsen
Solution Approach 1:
The bimetallic composition of silver and gold nanoparticles provides synergistic effects where gold reduces the required concentration of silver for effective antimicrobial activity, thereby maintaining potency while reducing toxicity associated with high silver concentrations.
3Ease of operation
If single-drug chemotherapeutic agents are used, then treatment simplicity is maintained, but efficacy against drug-resistant cancer cells deteriorates
Solution Approach 1:
The patent merges multiple therapeutic functions into a single bimetallic nanoparticle system that combines antimicrobial activity (silver) with anticancer activity (gold catalytic properties). This allows simultaneous treatment of infections and cancer with one agent, maintaining simplicity while overcoming drug resistance.
Solution Approach 2:
The bimetallic nanoparticle serves multiple functions: antimicrobial activity, anticancer activity through catalytic ROS generation, and potential imaging capabilities. This multi-functionality allows a single agent to address multiple therapeutic needs, including overcoming drug resistance.
4Reliability
If platinum-based chemotherapeutic drugs are used, then anticancer activity is achieved, but systemic toxicity particularly to kidneys worsens
Solution Approach 1:
The patent extracts the anticancer function from platinum-based drugs and transfers it to gold nanoparticles, which provide similar catalytic ROS generation activity but with significantly reduced systemic toxicity, particularly nephrotoxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition demonstrates synergistic increased stability and potency against drug-resistant infections and tumors, with enhanced antimicrobial and anticancer effects.
Implementation Method 1
silver nanoparticles... corrode and dissolve in vivo yielding Ag+ ions that induce reactive oxygen species (ROS)
Implementation Method 2
A nanoparticle composition combining metals like silver, gold, platinum, and surfactants with antibiotics and drugs, such as tetracycline and doxorubicin, to enhance stability and efficacy
Data Source
AI summary
The invention is directed to a composition of metal particles and methods of manufacturing and using the composition in the treatment of microbial infections and cancer. The particles can be nanoparticles having coupled thereto at least one of a surfactant, an antibiotic, and a drug. The particles of the invention achieve enhanced stability, enhanced cytotoxicity, and enhanced antimicrobial activity through novel combinations of metals, surfactants, antibiotics, and drugs.


